The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aadi Bioscience Inc | Common | 00032Q104 | 6,456,277 | 509,572 | SH | SOLE | 509,572 | 0 | 0 | |||
Aclaris Therapeutics, Inc. | Common | 00461U105 | 7,269,925 | 898,631 | SH | SOLE | 898,631 | 0 | 0 | |||
Aligos Therapeutics Inc | Common | 01626L105 | 3,100,104 | 3,547,030 | SH | SOLE | 3,547,030 | 0 | 0 | |||
Allakos Inc | Common | 01671P100 | 18,334,596 | 4,120,134 | SH | SOLE | 4,120,134 | 0 | 0 | |||
ALX Oncology Holdings Inc | Common | 00166B105 | 19,074,617 | 4,220,048 | SH | SOLE | 4,220,048 | 0 | 0 | |||
Amyris, Inc | Common | 03236M200 | 10,541,126 | 7,750,828 | SH | SOLE | 7,750,828 | 0 | 0 | |||
Arcellx Inc. | Common | 03940C100 | 8,956,868 | 290,713 | SH | SOLE | 290,713 | 0 | 0 | |||
Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 3,490,239 | 137,411 | SH | SOLE | 137,411 | 0 | 0 | |||
Aslan Pharmaceuticals Ltd | ADS | 04522R101 | 1,636,364 | 2,840,909 | SH | SOLE | 2,840,909 | 0 | 0 | |||
Astria Therapeutics Inc | Common | 04635X102 | 22,359,947 | 1,681,199 | SH | SOLE | 1,681,199 | 0 | 0 | |||
Avadel Pharmaceuticals PLC | ADR | 05337M104 | 34,454,772 | 3,761,438 | SH | SOLE | 3,761,438 | 0 | 0 | |||
Bellus Health Inc | Common | 07987C204 | 7,323,494 | 1,017,152 | SH | SOLE | 1,017,152 | 0 | 0 | |||
BioAtla Inc | Common | 09077B104 | 1,707,645 | 637,181 | SH | SOLE | 637,181 | 0 | 0 | |||
Bolt Therapeutics Inc | Common | 097702104 | 5,381,094 | 3,871,291 | SH | SOLE | 3,871,291 | 0 | 0 | |||
Chinook Therapeutics Inc | Common | 16961L106 | 20,190,296 | 872,151 | SH | SOLE | 872,151 | 0 | 0 | |||
Codexis, Inc | Common | 192005106 | 1,606,916 | 388,144 | SH | SOLE | 388,144 | 0 | 0 | |||
Cogent Biosciences Inc | Common | 19240Q201 | 21,525,413 | 1,994,941 | SH | SOLE | 1,994,941 | 0 | 0 | |||
Compass Therapeutics Inc | Common | 20454B104 | 11,628,195 | 3,556,023 | SH | SOLE | 3,556,023 | 0 | 0 | |||
DBV Technologies SA | Sponsored ADR | 23306J101 | 4,577,999 | 2,708,875 | SH | SOLE | 2,708,875 | 0 | 0 | |||
Dyne Therapeutics Inc | Common | 26818M108 | 6,654,436 | 577,642 | SH | SOLE | 577,642 | 0 | 0 | |||
Fulcrum Therapeutics Inc | Common | 359616109 | 1,567,500 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | |||
Genetron Holdings Ltd | ADS | 37186H100 | 104,570,306 | 8,124,174 | SH | SOLE | 8,124,174 | 0 | 0 | |||
Geron Corp | Common | 374163103 | 41,843,750 | 19,282,834 | SH | SOLE | 19,282,834 | 0 | 0 | |||
Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | 2,723,008 | 1,463,983 | SH | SOLE | 1,463,983 | 0 | 0 | |||
Harmony Biosciences Holdings Inc | Common | 413197104 | 85,093,965 | 2,606,247 | SH | SOLE | 2,606,247 | 0 | 0 | |||
Homology Medicines, Inc. | Common | 438083107 | 381,170 | 370,068 | SH | SOLE | 370,068 | 0 | 0 | |||
Immunic Inc | Common | 4525EP101 | 941,954 | 632,184 | SH | SOLE | 632,184 | 0 | 0 | |||
Impel NeuroPharma Inc | Common | 45258K109 | 4,038,705 | 2,884,789 | SH | SOLE | 2,884,789 | 0 | 0 | |||
Instil Bio Inc | Common | 45783C101 | 8,251,269 | 12,486,787 | SH | SOLE | 12,486,787 | 0 | 0 | |||
IO Biotech Inc | Common | 449778109 | 5,654,147 | 3,015,545 | SH | SOLE | 3,015,545 | 0 | 0 | |||
Iovance Biotherapeutics Inc | Common | 462260100 | 4,002,398 | 655,057 | SH | SOLE | 655,057 | 0 | 0 | |||
KalVista Pharmaceuticals Inc. | Common | 483497103 | 6,728,223 | 856,008 | SH | SOLE | 856,008 | 0 | 0 | |||
Legend Biotech Corp Sponsored | SPONSORED ADS | 52490G102 | 11,783,763 | 244,375 | SH | SOLE | 244,375 | 0 | 0 | |||
Merus NV | Common | N5749R100 | 6,506,240 | 353,600 | SH | SOLE | 353,600 | 0 | 0 | |||
Minerva Surgical Inc | Common | 60343F106 | 486,339 | 2,215,667 | SH | SOLE | 2,215,667 | 0 | 0 | |||
Olema Pharmaceuticals Inc | Common | 68062P106 | 5,862,617 | 1,689,515 | SH | SOLE | 1,689,515 | 0 | 0 | |||
Precision Biosciences Inc | Common | 74019P108 | 105,696 | 140,255 | SH | SOLE | 140,255 | 0 | 0 | |||
Rezolute Inc | Common | 76200L309 | 939,788 | 489,473 | SH | SOLE | 489,473 | 0 | 0 | |||
Sera Prognostics Inc | Common | 81749D107 | 7,108,522 | 1,856,011 | SH | SOLE | 1,856,011 | 0 | 0 | |||
Sinovac Biotech Ltd. | SHS | P8696W104 | 615,369,410 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | |||
Tarsus Pharmaceuticals Inc | Common | 87650L103 | 28,435,854 | 2,262,200 | SH | SOLE | 2,262,200 | 0 | 0 | |||
Terns Pharmaceuticals Inc | Common | 880881107 | 78,830,625 | 6,657,992 | SH | SOLE | 6,657,992 | 0 | 0 | |||
Vaxcyte Inc | Common | 92243G108 | 21,719,960 | 579,508 | SH | SOLE | 579,508 | 0 | 0 | |||
VectivBio Holding AG | Common | H9060V101 | 19,856,383 | 2,333,300 | SH | SOLE | 2,333,300 | 0 | 0 | |||
Ventyx Biosciences Inc | Common | 92332V107 | 20,169,513 | 602,075 | SH | SOLE | 602,075 | 0 | 0 | |||
Verona Pharma PLC | ADS | 925050106 | 85,338,353 | 4,249,918 | SH | SOLE | 4,249,918 | 0 | 0 | |||
Viridian Therapeutics Inc | Common | 92790C104 | 42,693,586 | 1,678,207 | SH | SOLE | 1,678,207 | 0 | 0 | |||
Zai Lab Ltd ADR | ADR | 98887Q104 | 13,857,446 | 416,640 | SH | SOLE | 416,640 | 0 | 0 |